Natural course of untreated microalbuminuria in children and adolescents with type 1 diabetes and the importance of diabetes duration and immigrant status: Longitudinal analysis from the prospective nationwide German and Austrian diabetes survey DPV

European Journal of Endocrinology

Volumn 166, Issue 3, 2012, Pages 493-501

  Galler, Angela ^a   Haberland, Holger ^b   Näke, Andrea ^c   Hofer, Sabine ^d   Holder, Martin ^e   Raile, Klemens ^a   Holl, Reinhard W ^f  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SANA KLINIKUM OFFENBACH   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e OLGAHOSPITAL   (Germany)

^f UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; AUSTRIA; BODY MASS; CHILD; CHILD HEALTH CARE; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GERMANY; HEALTH SURVEY; HUMAN; IMMIGRATION; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ADOLESCENT; AGE FACTORS; ALBUMINURIA; AUSTRIA; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; EMIGRANTS AND IMMIGRANTS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84857982948     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0695     Document Type: Article

References (41)

1. Bogdanović R. Diabetic nephropathy in children and adolescents. Pediatric Nephrology 2008 23 507-525. (doi:10.1007/s00467-007-0583-2)
2. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C & Parving HH. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 2004 328 1105-1109. (doi:10.1136/bmj.38070.450891.FE)
3. Vergouwe Y, Soedamah-Muthu SS, Zgibor J, Chaturvedi N, Forsblom C, Snell-Bergeon JK, Maahs DM, Groop PH, Rewers M, Orchard TJ, Fuller JH & Moons KG. Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia 2010 53 254-262. (doi:10.1007/s00125-009-1585-3)
4. Chiarelli F, Trotta D, Verrotti A & Mohn A. Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus. Pediatric Diabetes 2002 3 113-124. (doi:10.1034/j.1399-5448.2002.30209.x)
5. Rossing P, Hougaard P & Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 2002 25 859-864. (doi:10.2337/diacare.25.5.859)
6. William J, Hogan D & Batlle D. Predicting the development of diabetic nephropathy and its progression. Advances in Chronic Kidney Disease 2005 12 202-211. (doi:10.1053/j.ackd.2005.02.001)
7. Rogus JJ, Poznik GD, Pezzolesi MG, Smiles AM, Dunn J, Walker W, Wanic K, Moczulski D, Canani L, Araki S, Makita Y, Warram JH &Krolewski AS. High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach. Diabetes 2008 57 2519-2526. (doi:10.2337/db07-1086)
8. Gallego PH, Bulsara MK, Frazer F, Lafferty AR, Davis EA &Jones TW. Prevalence and risk factors for microalbuminuria in a population-based sample of children and adolescents with T1DM in Western Australia. Pediatric Diabetes 2006 7 165-172. (doi:10.1111/j.1399-543X.2006.00164.x)
9. Dost A, Klinkert C, Kapellen T, Lemmer A, Naeke A, Grabert M, Kreuder J & Holl RW & DPV Science Initiative. Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type 1 diabetes. Diabetes Care 2008 31 720-725. (doi:10.2337/dc07-0824)
10. Perrin NE, Torbjörnsdotter T, Jaremko GA & Berg UB. Risk markers of future microalbuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetes patients. Pediatric Diabetes 2010 11 305-313. (doi:10.1111/j.1399-5448.2009.00595.x)
11. Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM &Mauer M & International Diabetic Nephropathy Study Group. The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 2005 54 2164-2171. (doi:10.2337/diabetes.54.7.2164)
12. Stone ML, Craig ME, Chan AK, Lee JW, Verge CF & Donaghue KC. Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: a longitudinal study. Diabetes Care 2006 29 2072-2077. (doi:10.2337/dc06-0239)
13. Alleyn CR, Volkening LK, Wolfson J, Rodriguez-Ventura A, Wood JR & Laffel LM. Occurrence of microalbuminuria in young people with type 1 diabetes: importance of age and diabetes duration. Diabetic Medicine 2010 27 532-537. (doi:10.1111/j.1464-5491.2010.02983.x)
14. Donaghue K, Chiarelli F, Trotta D, Allgrove J & Dahl-Jorgensen K &ISPAD Clinical Practice Consensus Guidelines 2009 Compendium. Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatric Diabetes 2009 10 195-203. (doi:10.1111/j.1399-5448.2009. 00576.x)
15. Kromeyer-Hauschild K, Wabitsch M, Geller F, Ziegler A, Geiß HC, Hesse V, Hippel Av, Jäger U, Johnsen D, KiessW, KorteW, Kunze D, Menner K, Müller M, Niemann-Pilatus A, Remer T, Schäfer T, Wittchen HU, Zabransky S, Zellner K & Hebebrand J. Perzentile für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift für Kinderheilkunde2001149807-818. (doi:10.1007/s001120170107)
16. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM &Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2002 25 750-786. (doi:10.2337/diacare.25.4.750)
17. de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, SteffesMW, Sun W, Zinman B & Brunzell JD & for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Archives of Internal Medicine 2011 171 412-420. (doi:10.1001/archinternmed.2011.16)
18. Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen. Deutsches Ärzteblatt 2008 105 A341-A355.
19. Gerstl EM, Rabl W, Rosenbauer J, Gröbe H, Hofer SE, Krause U &Holl RW. Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. European Journal of Pediatrics 2008 167 447-453. (doi:10.1007/s00431-007-0586-9)
20. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National high blood pressure education program working group on hypertension control in children and adolescents. Pediatrics 1996 98 649-658.
21. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM & Selby JV. Ethnic disparities in diabetic complications in an insured population. Journal of the American Medical Association 2002 287 2519-2527. (doi:10.1001/jama.287. 19.2519)
22. Lopes AA. End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations. Ethnicity & Disease 2009 19 (Suppl 1) S1-47-51.
23. Raymond NT, Varadhan L, Reynold DR, Bush K, Sankaranarayanan S, Bellary S, Barnett AH, Kumar S &O'Hare JP & UK Asian Diabetes Study Retinopathy Study Group. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care 2009 32 410-415. (doi:10.2337/dc08-1422)
24. Carter PJ, CutfieldWS, Hofman PL, Gunn AJ,Wilson DA, ReedPW&Jefferies C. Ethnicity and social deprivation independently influence metabolic control in children with type 1 diabetes. Diabetologia 2008 51 1835-1842. (doi:10.1007/s00125-008-1106-9)
25. O'Connell J, Yi R, Wilson C, Manson SM & Acton KJ. Racial disparities in health status: a comparison of the morbidity among American Indian and U.S. adults with diabetes. Diabetes Care 2010 33 1463-1470. (doi:10.2337/dc09-1652)
26. Singh GK, Kogan MD & Yu SM. Disparities in obesity and overweight prevalence among US immigrant children and adolescents by generational status. Journal of Community Health 2009 34 271-281. (doi:10.1007/s10900-009-9148-6)
27. Will B, Zeeb H & Baune BT. Overweight and obesity at school entry among migrant and German children: a cross-sectional study. BMC Public Health 2005 5 45. (doi:10.1186/1471-2458-5-45)
28. McBean AM, Li S, Gilbertson DT & Collins AJ. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. Diabetes Care 2004 27 2317-2324. (doi:10.2337/diacare.27.10.2317)
29. Lange M, Kamtsiuris P, Lange C, Schaffrath Rosario A, Stolzenberg H & Lampert T. Sociodemographic characteristics in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) - operationalisation and public health significance, taking as an example the assessment of general state of health. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2007 50 578-589. (doi:10.1007/s00103-007-0219-5)
30. Kleiser C, Mensink GB, Neuhauser H, Schenk L & Kurth BM. Food intake of young people with a migration background living in Germany. Public Health Nutrition 2010 13 324-330. (doi:10.1017/S1368980009991030)
31. Singh GK & Hiatt RA. Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979-2003. International Journal of Epidemiology 2006 35 903-919. (doi:10.1093/ije/dyl089)
32. Neu A, Willasch A, Ehehalt S, Kehrer M, Hub R & Ranke MB. Diabetes incidence in children of different nationalities: an epidemiological approach to the pathogenesis of diabetes. Diabetologia 2001 44 (Suppl 3) B21-B26. (doi:10.1007/PL00002948)
33. Amin R, Widmer B, Prevost AT, Schwarze P, Cooper J, Edge J, Marcovecchio L, Neil A, Dalton RN & Dunger DB. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 2008 336 697-701. (doi:10.1136/bmj.39478. 378241.BE)
34. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM,Warram JH &Krolewski AS. Regression of microalbuminuria in type 1 diabetes. New England Journal of Medicine 2003 348 2285-2293. (doi:10.1056/NEJMoa021835)
35. Svensson M, Eriksson JW & Dahlquist G. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care 2004 27 955-962. (doi:10.2337/diacare.27.4.955)
36. Salardi S, Balsamo C, Zucchini S, Maltoni G, Scipione M, Rollo A, Gualandi S & Cicognani A. High rate of regression from micro- macroalbuminuria to normoalbuminuria in children and adolescents with type 1 diabetes treated or not with enalapril: the influence of HDL cholesterol. Diabetes Care 2011 34 424-429. (doi:10.2337/dc10-1177)
37. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P &Holl RW. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007 30 2523-2528. (doi:10.2337/dc07- 0282)
38. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993 329 977-986. (doi:10.1056/NEJM199309303291401)
39. Marcovecchio ML, Dalton RN, Prevost AT, Acerini CL, Barrett TG, Cooper JD, Edge J, Neil A, Shield J, Widmer B, Todd JA &Dunger DB. Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care 2009 32 658-663. (doi:10.2337/dc08-1641)
40. Riihimaa PH, Knip M, Hirvelä H & Tapanainen P. Metabolic characteristics and urine albumin excretion rate in relation to pubertal maturation in type 1 diabetes. Diabetes/Metabolism Research and Reviews 2000 16 269-275. (doi:10.1002/1520-7560(2000)9999:9999<::AID-DMRR121>3.0.CO;2-Z)
41. Wadén J, Forsblom C, Thorn LM, Saraheimo M, Rosengård- Bärlund M, Heikkilä O, Hietala K, Ong K,Wareham N & Groop PH & FinnDiane Study Group. Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial. Diabetes 2009 58 1914-1920. (doi:10.2337/db08-1767)